170 related articles for article (PubMed ID: 29032825)
1. LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers.
Xia Z; Cochrane DR; Anglesio MS; Wang YK; Nazeran T; Tessier-Cloutier B; McConechy MK; Senz J; Lum A; Bashashati A; Shah SP; Huntsman DG
Gynecol Oncol; 2017 Dec; 147(3):642-647. PubMed ID: 29032825
[TBL] [Abstract][Full Text] [Related]
2. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
3. Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.
Linder A; Westbom-Fremer S; Mateoiu C; Olsson Widjaja A; Österlund T; Veerla S; Ståhlberg A; Ulfenborg B; Hedenfalk I; Sundfeldt K
Hum Reprod; 2024 May; 39(5):1141-1154. PubMed ID: 38459814
[TBL] [Abstract][Full Text] [Related]
4. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
[TBL] [Abstract][Full Text] [Related]
5. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8
Heinze K; Nazeran TM; Lee S; Krämer P; Cairns ES; Chiu DS; Leung SC; Kang EY; Meagher NS; Kennedy CJ; Boros J; Kommoss F; Vollert HW; Heitz F; du Bois A; Harter P; Grube M; Kraemer B; Staebler A; Kommoss FK; Heublein S; Sinn HP; Singh N; Laslavic A; Elishaev E; Olawaiye A; Moysich K; Modugno F; Sharma R; Brand AH; Harnett PR; DeFazio A; Fortner RT; Lubinski J; Lener M; Tołoczko-Grabarek A; Cybulski C; Gronwald H; Gronwald J; Coulson P; El-Bahrawy MA; Jones ME; Schoemaker MJ; Swerdlow AJ; Gorringe KL; Campbell I; Cook L; Gayther SA; Carney ME; Shvetsov YB; Hernandez BY; Wilkens LR; Goodman MT; Mateoiu C; Linder A; Sundfeldt K; Kelemen LE; Gentry-Maharaj A; Widschwendter M; Menon U; Bolton KL; Alsop J; Shah M; Jimenez-Linan M; Pharoah PD; Brenton JD; Cushing-Haugen KL; Harris HR; Doherty JA; Gilks B; Ghatage P; Huntsman DG; Nelson GS; Tinker AV; Lee CH; Goode EL; Nelson BH; Ramus SJ; Kommoss S; Talhouk A; Köbel M; Anglesio MS
J Pathol; 2022 Apr; 256(4):388-401. PubMed ID: 34897700
[TBL] [Abstract][Full Text] [Related]
6. Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma.
Su YF; Tsai EM; Chen CC; Wu CC; Er TK
Clin Chim Acta; 2019 Jul; 494():1-7. PubMed ID: 30851247
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing-based detection of germline L1-mediated transductions.
Tica J; Lee E; Untergasser A; Meiers S; Garfield DA; Gokcumen O; Furlong EE; Park PJ; Stütz AM; Korbel JO
BMC Genomics; 2016 May; 17():342. PubMed ID: 27161561
[TBL] [Abstract][Full Text] [Related]
8. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
[TBL] [Abstract][Full Text] [Related]
9. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.
Anglesio MS; Bashashati A; Wang YK; Senz J; Ha G; Yang W; Aniba MR; Prentice LM; Farahani H; Li Chang H; Karnezis AN; Marra MA; Yong PJ; Hirst M; Gilks B; Shah SP; Huntsman DG
J Pathol; 2015 Jun; 236(2):201-9. PubMed ID: 25692284
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.
Prowse AH; Manek S; Varma R; Liu J; Godwin AK; Maher ER; Tomlinson IP; Kennedy SH
Int J Cancer; 2006 Aug; 119(3):556-62. PubMed ID: 16506222
[TBL] [Abstract][Full Text] [Related]
11. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
[TBL] [Abstract][Full Text] [Related]
13. BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.
Mafficini A; Simbolo M; Parisi A; Rusev B; Luchini C; Cataldo I; Piazzola E; Sperandio N; Turri G; Franchi M; Tortora G; Bovo C; Lawlor RT; Scarpa A
Oncotarget; 2016 Jan; 7(2):1076-83. PubMed ID: 26745875
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.
Maru Y; Tanaka N; Ohira M; Itami M; Hippo Y; Nagase H
Gynecol Oncol; 2017 Feb; 144(2):377-383. PubMed ID: 27939411
[TBL] [Abstract][Full Text] [Related]
15. The role of p53 mutation in the carcinomas arising from endometriosis.
Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer in endometriosis: clinical and molecular aspects.
Lyttle B; Bernardi L; Pavone ME
Minerva Ginecol; 2014 Apr; 66(2):155-64. PubMed ID: 24848074
[TBL] [Abstract][Full Text] [Related]
17. Cancer Implications for Patients with Endometriosis.
Wilbur MA; Shih IM; Segars JH; Fader AN
Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
[TBL] [Abstract][Full Text] [Related]
18. Target-enriched next-generation sequencing reveals differences between primary and secondary ovarian tumors in formalin-fixed, paraffin-embedded tissue.
Crobach S; Ruano D; van Eijk R; Fleuren GJ; Minderhout I; Snowdowne R; Tops C; van Wezel T; Morreau H
J Mol Diagn; 2015 Mar; 17(2):193-200. PubMed ID: 25545608
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG
Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923
[TBL] [Abstract][Full Text] [Related]
20. Novel insights on the malignant transformation of endometriosis into ovarian carcinoma.
Gadducci A; Lanfredini N; Tana R
Gynecol Endocrinol; 2014 Sep; 30(9):612-7. PubMed ID: 24905724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
